Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease

Archives of Medical Science

Volumn 8, Issue 2, 2012, Pages 277-285

  Antczak, Adam ^a   Ciebiada, Maciej ^a   Pietras, Tadeusz ^a   Piotrowski, Wojciech J ^a   Kurmanowska, Zofia ^a   Górski, Paweł ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

8 isoprostane; Chronic obstructive pulmonary disease; Exhaled breath condensate; Exhaled eicosanoids

Indexed keywords

8 ISOPROSTANE; BUDESONIDE; CEFUROXIME AXETIL; FORMOTEROL; HYDROGEN PEROXIDE; IPRATROPIUM BROMIDE; LEUKOTRIENE B4; PEPTIDOLEUKOTRIENE; PREDNISONE; PROSTAGLANDIN E; PROSTAGLANDIN E2; PROSTAGLANDIN E4; ROXITHROMYCIN; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EXPIRED AIR; FEMALE; FOLLOW UP; HUMAN; ICOSANOID METABOLISM; LUNG INFECTION; MALE; NEBULIZATION; OXIDATIVE STRESS; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 84861466279     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.28555     Document Type: Article

References (31)

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Report, 2006 updated 2009.
2. Hodge SJ, Hodge GL, Holmes M, Reynolds PN. Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease. Cytometry B Clin Cytom 2004; 61: 27-34. (Pubitemid 39223367)
3. Stanescu D, Sanna A, Veriter C, et al. Airway obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-71. (Pubitemid 26086470)
4. MacNee W, Wiggs BB, Berzberg AS, Hogg JC. The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 1989; 6: 287-95.
5. Mio T, Romberger DJ, Thompson AB, Robbins RA, Reinnard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 1997; 155: 1770-6. (Pubitemid 27216691)
6. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999; 160: 1968-75. (Pubitemid 30004705)
7. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1773-7.
8. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 341-57. (Pubitemid 27351964)
9. Dekhujzen PNR, Aben KK, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 813-6. (Pubitemid 26327310)
10. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055-60.
11. Montuschi P, Collins JV, Ciabattoni G, et al. Increased 8-isoprostane as in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162: 1175-7.
12. Piotrowska VM, Piotrowski WJ, Kurmanowska Z, Marczak J, Górski P, Antczak A. Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids. Int J COPD 2010; 5: 107-17.
13. Hill AT, Bayley D, Stockley RA. The interpretation of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med 1999; 160: 893-8. (Pubitemid 29442027)
14. Seggev JS, Thornton WH, Edes TE. Serum leukotriene B4 levels in patients with chronic obstructive pulmonary disease. Chest 1991; 99: 289-91.
15. Piperno D, Pacheco Y, Hosni R, et al. Increased plasma levels of atrial natriuretic peptide, renin activity, and leukotriene C4 in chronic obstructive pulmonary disease. Chest 1993; 104: 454-9. (Pubitemid 23229515)
16. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104: 5-13. (Pubitemid 29364472)
17. Zakrzewski JT, Barnes NC, Costello JF, Piper PJ. Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 136: 779-82. (Pubitemid 18007393)
18. Jakobsson PJ, Thoren S, Morgenstern R, Mancici J, Ford-Huchinson A, Person B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Aci USA 1999; 96: 7220-5. (Pubitemid 29299642)
19. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Increased 8-isoprostane as non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000; 55: 205-9. (Pubitemid 30245970)
20. Antczak A, Nowak D, Krol M, Shariati B, Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acidreactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997; 10: 1231-41.
21. Piotrowski WJ, Antczak A, Marczak J, Nawrocka A, Kurmanowska Z, Górski P. Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis. Chest 2007; 132: 589-96. (Pubitemid 47282393)
22. 2 production by macrophages and neutrophils with homovanillic acid and horseradish peroxidase. J Immunol Methods 1983; 63: 347-57.
23. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary diseases. Am J Respir Crit Care Med 2001; 163: 1693-722.
24. Shindo K, Fukumura M, Miyakawa K. Plasma levels of leukotriene E4 during clinical course of bronchial asthma and the effect of oral prednisolone. Chest 1994; 105: 1038-41. (Pubitemid 24112786)
25. Nakamura H, Fuijishima S, Inoue T. Clinical and immuno - regulatory effects of roxithromycin in chronic respiratory tract infection. Eur Respir J 1999; 13: 1371-9. (Pubitemid 29357155)
26. 4 release from activated neutrophils. Proc Natl Acad Sci USA 1983; 80: 4349-53.
27. Dworski R, Murray JJ, Roberts LJ, et al. Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med 1999; 160: 1947-51. (Pubitemid 30004701)
28. Antczak A, Montuschi P, Kharitonov SA, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166: 301-6. (Pubitemid 34864417)
29. Montuschi P. Isoprostanes and other exhaled markers in respiratory diseases. Eur Respir Rev 1999; 9: 249-53. (Pubitemid 30018916)
30. Nowak D, Antczak A, Król M, et al. Increased content of hydrogen peroxide in expired breath of cigarette smokers. Eur Respir J 1996; 9: 652-7. (Pubitemid 26167866)
31. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003; 124: 1373-80. (Pubitemid 37290047)